These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31173125)

  • 1. Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017.
    Guadamuz JS; Alexander GC; Chaudhri T; Trotzky-Sirr R; Qato DM
    JAMA Netw Open; 2019 Jun; 2(6):e195388. PubMed ID: 31173125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies.
    Graves RL; Andreyeva E; Perrone J; Shofer FS; Merchant RM; Meisel ZF
    J Addict Med; 2019; 13(4):272-278. PubMed ID: 30585876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone Availability and Cost After Transition to an Over-the-Counter Product.
    Marley GT; Annis IE; Egan KL; Delamater P; Carpenter DM
    JAMA Health Forum; 2024 Jul; 5(7):e241920. PubMed ID: 39058509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone Accessibility by Standing Order in North Carolina Community Pharmacies.
    Marley G; Annis IE; Ostrach B; Egan K; Delamater PL; Bell R; Dasgupta N; Carpenter DM
    J Am Pharm Assoc (2003); 2024; 64(3):102021. PubMed ID: 38307248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in Access.
    Egan KL; Foster SE; Knudsen AN; Lee JGL
    Am J Prev Med; 2020 May; 58(5):699-702. PubMed ID: 32005590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessibility of Naloxone in Pharmacies Registered Under the Illinois Standing Order.
    Quincy Moore P; Ellis K; Simmer P; Waetjen M; Almirol E; Salisbury-Afshar E; Pho MT
    West J Emerg Med; 2024 Jul; 25(4):457-464. PubMed ID: 39028230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
    Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
    Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone Accessibility Under the State Standing Order Across Mississippi.
    Gravlee E; Ramachandran S; Cafer A; Holmes E; McGregor J; Jordan T; Rosenthal M
    JAMA Netw Open; 2023 Jul; 6(7):e2321939. PubMed ID: 37410464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.
    Stopka TJ; Donahue A; Hutcheson M; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with naloxone availability and dispensing through Michigan's pharmacy standing order.
    Dahlem CH; Myers M; Goldstick J; Stevenson JG; Gray G; Rockhill S; Dora-Laskey A; Kellenberg J; Brummett CM; Kocher KE
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):454-463. PubMed ID: 35405078
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacist's role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution.
    Burrell A; Ethun L; Fawcett JA; Rickard-Aasen S; Williams K; Kearney SM; Pringle JL
    J Am Pharm Assoc (2003); 2017; 57(2S):S73-S77.e1. PubMed ID: 28109629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pharmacist counseling to enhance the accessibility of naloxone nasal spray to patients in a community pharmacy setting.
    Napoli K; Grant M; Remines J; Nadpara P; Goode JR
    J Am Pharm Assoc (2003); 2021; 61(4S):S127-S134. PubMed ID: 33441280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
    Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA.
    Hill LG; Loera LJ; Evoy KE; Renfro ML; Torrez SB; Zagorski CM; Perez JC; Jones SM; Reveles KR
    Addiction; 2021 Jun; 116(6):1505-1511. PubMed ID: 33140519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of Naloxone in Pharmacies and Knowledge of Pharmacy Staff Regarding Dispensing Naloxone to Younger Adolescents.
    Jimenez DE; Singer MR; Adesman A
    J Adolesc Health; 2019 Nov; 65(5):698-701. PubMed ID: 31540779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states.
    Hill LG; Loera LJ; Torrez SB; Puzantian T; Evoy KE; Ventricelli DJ; Eukel HN; Peckham AM; Chen C; Ganetsky VS; Yeung MS; Zagorski CM; Reveles KR
    Drug Alcohol Depend; 2022 Aug; 237():109518. PubMed ID: 35691255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
    Melaragni F; Levy C; Pedrazzi J; Andersen M
    J Am Pharm Assoc (2003); 2019; 59(4):550-554.e2. PubMed ID: 31109812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to naloxone at community pharmacies under the Massachusetts statewide standing order.
    Wu C; Brown T; Moreno JL
    J Am Pharm Assoc (2003); 2020; 60(4):647-652. PubMed ID: 31843374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users.
    Acharya M; Chopra D; Hayes CJ; Teeter B; Martin BC
    Value Health; 2020 Apr; 23(4):451-460. PubMed ID: 32327162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.